Dusa gets Brazilian OK for acne solution

Dusa Pharmaceuticals Inc., which makes treatments for acne and rosacea, said today that Stiefel Laboratories Inc., its marketing partner for Latin America, has received Brazilian regulatory approval for one of its acne drugs.

Dusa officials said additional launches of the drug are expected to follow in a number of other Latin American countries, subject to regulatory approvals.

Levulan Kerastick is a solution to prime the skin, making affected areas more sensitive to light treatment. (AP)